Cite
HARVARD Citation
Macek Jilkova, Z. et al. (2019). Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment. Clinical and translational gastroenterology. 10 (7), p. . [Online].